Future Innovation - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Future Innovation
Presidents of leading associations offer views on the industry's future.

Pharmaceutical Technology
Volume 36, Issue 7, pp. 142, 141

David Y. Mitchell, PhD, President, American Association of Pharmaceutical Scientists (AAPS)

"The pharmaceutical sciences are moving towards a new era and continue to adapt, evolve, and thrive despite some well-documented growing pains. In the US and EU, there has been a pronounced shift to produce a leaner R&D process in large pharma, with a move in workforce towards smaller companies, CROs, CMOs, and biotechnology startups. Whereas, in Asia Pacific, pharma is expanding their footprint with clinical trials and new manufacturing sites, new government and private industry technical centers to promote basic science research, and a goal of becoming one of the top research and marketing regions of the world.

"The industry now not only looks internally for new drug-development leads, but also towards smaller pharma, biotechnology companies, and academic institutions, with their focused research programs and their quick and nimble operations, to bring forth the potential medicines of tomorrow. Further, the pharma industry is expanding globally to leverage new markets and low-cost alternatives for drug development.

"AAPS would like to congratulate Pharmaceutical Technology on its 35th anniversary. We're looking forward to continuing our strong partnership as we navigate these changes that will impact of our industry for the next 35 years."


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here